Advanced Proteome Therapeutics Corporation

BST:0E81 Stock Report

Market Cap: €140.0k

Advanced Proteome Therapeutics Corporation Company Information

Advanced Proteome Therapeutics Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Advanced Proteome Therapeutics Corporation
  • Ticker: 0
  • Exchange: BST
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$205.635k
  • Listing Market Cap: CA$139.958k
  • Shares Outstanding: 41.13m
  • Website: https://www.advancedproteome.com

Location

  • Advanced Proteome Therapeutics Corporation
  • 8337 Eastlake Drive
  • Suite 104
  • Burnaby
  • British Columbia
  • V5A 4W2
  • Canada


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APTC.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 1989
APC.HTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 1989
0DB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1989
0BST (Boerse-Stuttgart)YesCommon SharesDEEURSep 1989

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/03/04 00:00
End of Day Share Price 2023/12/06 00:00
Earnings2023/04/30
Annual Earnings2022/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.